Mayo Clinic's 'medical school of the future' tops April news

April brought FDA approvals and the passing of one of the ophthalmology world’s most distinguished figures, but the AMA’s announcement that it was working with the Mayo Clinic to revamp medical schools for a new generation of physicians was the most read breaking news story on Healio.com/OSN this month.

Here are the top five most read stories in April:

1. AMA, Mayo Clinic working to create ‘medical school of the future’

The two organizations are working together with a 32-school consortium to develop innovative ideas regarding physician training. Read more.

2. Better quality of vision with LASIK vs. PRK did not last after 1 month postop

A study showed LASIK patients had better visual quality at 1 month postop compared with PRK patients, but the quality of vision was not significantly better at subsequent follow-up visits. Read more.

3. FDA approves Lucentis for all forms of diabetic retinopathy

While Lucentis was previously approved for some forms of DR, the FDA has now granted it approval for all forms, including “with or without diabetic macular edema.” Read more.

4. Ophthalmology world mourns loss of William Tasman, MD, FACS

William Tasman, MD, FACS, former Wills Eye ophthalmologist-in-chief and one of the leaders in pioneering treatments for retinopathy of prematurity, died March 28 at the age of 87. Read more.

5. Aura Biosciences’ ocular melanoma treatment receives fast track designation

An investigational targeted therapy for ocular melanoma, AU-011, was fast-tracked by the FDA. Read more.

April brought FDA approvals and the passing of one of the ophthalmology world’s most distinguished figures, but the AMA’s announcement that it was working with the Mayo Clinic to revamp medical schools for a new generation of physicians was the most read breaking news story on Healio.com/OSN this month.

Here are the top five most read stories in April:

1. AMA, Mayo Clinic working to create ‘medical school of the future’

The two organizations are working together with a 32-school consortium to develop innovative ideas regarding physician training. Read more.

2. Better quality of vision with LASIK vs. PRK did not last after 1 month postop

A study showed LASIK patients had better visual quality at 1 month postop compared with PRK patients, but the quality of vision was not significantly better at subsequent follow-up visits. Read more.

3. FDA approves Lucentis for all forms of diabetic retinopathy

While Lucentis was previously approved for some forms of DR, the FDA has now granted it approval for all forms, including “with or without diabetic macular edema.” Read more.

4. Ophthalmology world mourns loss of William Tasman, MD, FACS

William Tasman, MD, FACS, former Wills Eye ophthalmologist-in-chief and one of the leaders in pioneering treatments for retinopathy of prematurity, died March 28 at the age of 87. Read more.

5. Aura Biosciences’ ocular melanoma treatment receives fast track designation

An investigational targeted therapy for ocular melanoma, AU-011, was fast-tracked by the FDA. Read more.